Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA recalls more than 7,000 bottles of antidepressant
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
Thousands of bottles of popular antidepressant recalled: 3 things to know
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from the U.S. Food and Drug Administration.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The Duloxetine Delayed-Release Capsules' voluntary recall began on Oct. 10 after the FDA deemed the medication the second-highest risk classification. Over 7,100 bottles of Duloxetine were recalled, including 500 delayed-release 20mg capsules. The lot number is 220128, and the expiration date is 12/2024, per the FDA report.
Thousands of bottles of common antidepressant Cymbalta recalled by FDA over cancer-causing chemical
Thousands of bottles of a commonly prescribed antidepressant drug were recalled because they contained a suspected cancer-causing chemical.
Urgent recall of popular antidepressant after cancer-causing compound detected
The FDA recently announced a recall of over 7,000 bottles of duloxetine after detecting elevated levels of N-nitroso-duloxetine, a potentially harmful compound that increases cancer risks
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
Antidepressant recalled: 2nd-highest FDA risk level; drug contains cancerous chemical
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high levels of a cancer-causing chemical.
Antidepressant recall: FDA upgrades risk level due to cancer-causing chemical
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, according to agency records and reported by SILive.com sister site NJ.com. Duloxetine is used to treat depression, anxiety and nerve pain caused by fibromyalgia.
Duloxetine antidepressant recalled over presence of toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
FDA issues recall for antidepressant drug
Thousands of New Yorkers may have to check their medicine cabinets; the Federal Drug Administration has issued a recall for a common medicine used to treat depression the agency
Thousands of antidepressants recalled after toxic cancer causing chemical found
The FDA has ordered an urgent recall of the antidepressant duloxetine, which is sold under the brand name Cymbalta, due to the presence of a toxic chemical. The toxic chemical in question is called N-nitroso-duloxetine,
8h
This antidepressant is being recalled: Here’s why
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...
2d
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
NK troops in RU confirmed
Linked to E. coli outbreak
Trespassing charge upheld
Arlington visit records order
Veteran film producer dies
2 US troops injured in raid
MO court upholds release
Hashem Safieddine killed
Dodgers legend dies
Giant ‘ghost’ fish spotted
To close 150 locations
First father-son duo in NBA
Funds corruption guilty plea
DOJ alleges racial bias
Lake Erie toxic algae study
US fines American Airlines
Gun assault trial delayed
Apple, Goldman Sachs fined
FDA approves RSV vaccine
GA election rules appeal
G7 Ukraine loan advances
Bird flu infects 4 in WA
To appear on Rogan podcast
FAA finalizes safety rules
Brain stimulation study
Six indicted for fraud in Ohio
Hospitals' IV fluid shortage
Feedback